Yesterday, European stocks closed mixed. The Stoxx Europe 600 Index rebounded 0.20%, Germany's DAX 30 rose 0.41% and the U.K.'s FTSE 100 was up 0.43%, while France's CAC 40 declined 0.40%.
55% of STOXX 600 constituents traded higher yesterday.
29% of the shares trade above their 20D MA vs 26% Monday (below the 20D moving average).
51% of the shares trade above their 200D MA vs 51% Monday (below the 20D moving average).
The Euro Stoxx 50 Volatility index eased 1.77pt to 28.11, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: Pers. & House. Goods
3mths relative low: Insurance, Banks
Europe Best 3 sectors
energy, automobiles & parts, technology
Europe worst 3 sectors
insurance, travel & leisure, basic resources
The 10yr Bund yield fell 5bps to -0.53% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -21bps (above its 20D MA).
GE 07:00: Oct GfK Consumer Confidence, exp.: -1.8
FR 08:15: Sep Markit Composite PMI Flash, exp.: 51.6
FR 08:15: Sep Markit Services PMI Flash, exp.: 51.5
FR 08:15: Sep Markit Manufacturing PMI Flash, exp.: 49.8
GE 08:30: Sep Markit Composite PMI Flash, exp.: 54.4
GE 08:30: Sep Markit Services PMI Flash, exp.: 52.5
GE 08:30: Sep Markit Manufacturing PMI Flash, exp.: 52.2
EC 09:00: ECB Non-Monetary Policy Meeting
EC 09:00: Sep Markit Composite PMI Flash, exp.: 51.9
EC 09:00: Sep Markit Services PMI Flash, exp.: 50.5
EC 09:00: Sep Markit Manufacturing PMI Flash, exp.: 51.7
UK 09:30: Sep Markit/CIPS Manufacturing PMI Flash, exp.: 55.2
UK 09:30: Sep Markit/CIPS UK Services PMI Flash, exp.: 58.8
UK 09:30: Sep Markit/CIPS Composite PMI Flash, exp.: 59.1
In Asian trading hours, the U.S. dollar strengthened further, as EUR/USD slid to 1.1680 and GBP/USD slipped to 1.2721. USD/JPY held gains at 105.12. NZD/USD fell further to 0.6620. This morning, the Reserve Bank of New Zealand kept its benchmark rate unchanged at 0.25% as expected. RBNZ said "further monetary stimulus may be needed", citing "a severe and prolonged economic downturn".
Spot gold was little changed at $1,901 an ounce.
#UK - IRELAND#
Halma, a manufacturer of hazard detection and life protection products, posted a trading update for the period from April 1 to date: "At the end of the first quarter we reported that revenue was 13% lower than last year on an organic constant currency basis. Since then, the Group's revenue trends have gradually improved, (...) Order intake was ahead of revenue albeit marginally down on the same period last year. (...) the Board continues to expect Adjusted profit before tax for FY2021 to be 5%-10% below FY2020 and more weighted to the second half than in previous years." Separately, the company announced that Paul Walker has indicated his intention to retire from his role as Chairman by July.
RELX, a provider of information-based analytics and decision tools, announced that Paul Walker, currently Chairman of Halma, will succeed Sir Anthony Habgood as Chairman.
Fresenius, a health care group, was upgraded to "overweight" from "equalweight" at Barclays.
Wacker Chemie, a chemical company, was upgraded to "buy" from "hold" at HSBC.
Veolia, a resource management company, is ready to engage in discussion with Engie regarding its proposal to acquire Engie's stake in Suez, according to news agency Agence France-Presse.
Sanofi and GlaxoSmithKline, the two pharmaceutical groups, said they have signed agreements with the Canadian government to supply up to 72 million doses of adjuvanted COVID-19 vaccine. Financial terms were not disclosed.
Orpea, a dependency care company, announced that 1H net income declined 36.3% on year to 73 million euros and EBITDA dropped 5.5% to 439 million euros on revenue of 1.90 billion euros, up 3.5%.
Proximus, a mobile telecommunications company, was downgraded to "neutral" from "buy" at Citigroup.
From a chartist point of view, the share is capped by a short term declining trend line since June. Furthermore, the 50 DMA is playing a resistance role, while a resistance at 49% maintains the RSI. Above the overlap at 17.5E look for 13.6E and 9.2E in extension.
Source: TradingView, GAIN Capital
Snam, an energy infrastructure company, was upgraded to "buy" from "sell" at Goldman Sachs.
Coloplast, a medical devices manufacturer, was downgraded to "underweight" from "equalweight" at Barclays.
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.